XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2022
Revenue From Contract With Customer [Abstract]  
Schedule of Disaggregated Revenue The following table presents our disaggregated revenue for the periods presented (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Immune Medicine revenue

 

 

 

 

 

 

 

 

Service revenue

 

$

7,113

 

 

$

4,048

 

Collaboration revenue

 

 

13,703

 

 

 

16,057

 

Total Immune Medicine revenue

 

 

20,816

 

 

 

20,105

 

MRD revenue

 

 

 

 

 

 

 

 

Service revenue

 

 

14,804

 

 

 

11,337

 

Regulatory milestone revenue

 

 

3,000

 

 

 

7,000

 

Total MRD revenue

 

 

17,804

 

 

 

18,337

 

Total revenue

 

$

38,620

 

 

$

38,442